Cooperative CCL2/CCR2 and HGF/MET signaling enhances breast cancer growth and invasion associated with metabolic reprogramming

Cooperative CCL2/CCR2 and HGF/MET signaling enhances breast cancer growth and invasion associated with metabolic reprogramming

With over 60,000 cases diagnosed in women annually, ductal carcinoma in situ (DCIS) is the most common form of pre-invasive breast cancer in the US. Despite standardized therapy, under-treatment and over-treatment are prevailing concerns. By understanding the mechanisms regulating DCIS progression,...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Fang, Yuuka Kozai, Diana S. Acevedo, Rebecca Brodine, Haasini S. Gorrepati, Nizhoni Arviso, Paige Cote, Alala Thompson, Zachary Gerdes, Ashley Espinoza, Nick Bergeron, Audrey Brownfield, Nikki Cheng
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Cancer Biology & Therapy
Subjects:
CCL2
HGF
chemokine
CCR2
MET
metabolism
Online Access:https://www.tandfonline.com/doi/10.1080/15384047.2025.2535824
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items